But now, Pfizer has tapped Goldman Sachs to gauge interest from potential buyers such as private equity shops and other ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Pfizer hopes to benefit from that hype as it works feverishly on a weight loss pill it believes could be one of the first to hit the market soon. While there are approved weight loss injectable ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Fact checked by Nick BlackmerMultiple pharmaceutical companies are developing oral versions of GLP-1 medications like Ozempic ...

Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

NEW YORK, Nov 19 (Reuters) - A federal judge on Tuesday rejected Pfizer's (PFE.N), opens new tab bid to recoup about $75.2 million left over from a U.S. Securities and Exchange Commission insider ...

Pfizer is considering selling its hospital drugs unit, known as Pfizer Hospital, to reduce debt and streamline operations. This move follows pressure from activist investors and a history of large ...

Pfizer Limited is expanding its manufacturing capacity and focusing on research and development said Meenakshi Nevatia ...

Pfizer India expanding R&D, manufacturing, and adult vaccination initiatives, showcasing commitment to the country's ...

Pfizer Limited Managing Director Meenakshi Nevatia has reaffirmed the company dedication to India highlighting its extensive ...

Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics and sterile injectables used in hospitals and clinics, Reuters reported.